Related Experiment Video
Updated: Jul 4, 2026
03:59
Therapeutic Massage for Psychological Well-being in Geriatric Oncology
Published on: May 22, 2026
[Geriatric assessment in the oncology setting]
1Programme lyonnais d'oncogériatrie, Centre Léon-Bérard, 28, rue Laennec, 69373 Lyon Cedex 08, France. terret@lyon.fnclcc.fr
Bulletin Du Cancer
|January 28, 2009
Summary
Comprehensive geriatric assessment (CGA) is key for elderly cancer patients. Healthy older adults may not need CGA and can benefit from standard cancer treatment.
Area of Science:
- Geriatric Medicine
- Oncology
Context:
- Optimal management of elderly cancer patients requires integrating tumor assessment with geriatric evaluation.
- Comprehensive Geriatric Assessment (CGA) is the established standard for evaluating older adults.
- Specialized geriatric units and expert teams are crucial for effective CGA implementation.
Purpose:
- To explore alternative geriatric assessment tools in oncology.
- To identify older patients who may not benefit from full CGA.
- To differentiate healthy elderly individuals from those requiring pre-treatment CGA.
Summary:
- Multidimensional geriatric assessment and screening tools offer an alternative to full CGA in oncology.
- These tools help oncologists identify older patients who can proceed with cancer treatment without extensive pre-treatment evaluation.
- Healthy older patients show no additional benefit from CGA and respond similarly to younger patients regarding cancer treatment outcomes.
Impact:
- Refines patient selection for comprehensive geriatric assessment, optimizing resource allocation.
- Facilitates timely cancer treatment for healthy elderly individuals.
- Improves the precision of geriatric care strategies in oncology.
Related Concept Videos
01:15Drug Dosing: Geriatric Patients
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
01:27Pharmacodynamics in Geriatric Patients: Effects of Age
Age-related pharmacokinetic changes are extensively documented, but understanding age-related pharmacodynamic alterations is relatively limited. This knowledge gap can be partly attributed to the complexity of developing appropriate measures of drug responses compared to bioanalytical methods for determining drug concentrations.Most information regarding age-related differences in human pharmacodynamics originates from cross-sectional studies. However, these studies assume that observed mean...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
01:00Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are not...
01:22Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Metabolism
Geriatric patients show significant variation in how their bodies process medications, which can change how effective and safe treatments are. The liver is the primary organ where drug metabolism occurs, involving two main types of chemical reactions: phase I and II. Phase I metabolism is driven by the cytochrome P450 enzyme system, which includes key types such as CYP3A, CYP2D6, and CYP2C9. Research indicates that while aging doesn't notably alter the levels or activity of these enzymes, it...